One of the papers I read compared and contrasted the antibody that Pfizer used in their development vs the one that Moderna used in their development, with the conclusion that the Moderna "provoked" antibody was slightly more effective at preventing an infection from taking hold.
And based on that understanding (which may be flawed, please let me know if it is) then having a better 'target' antibody that you are trying to provoke the immune system to create, would make an MRNA vaccine more effective.
“If it does,” he added, “it might provide a new therapeutic and also contribute to new vaccine strategies.”
Maybe you know, is this just for therapeutics and not vaccines?
Edit: looks like someone else answered this below....
[0] unless the lab-gnerated antibody is "seeing" a different part of the virus that the current vaccine doesn't see, in which case targeting the new spot in the virus is an obvious "next move".